New
Dama Health
The AI engine Fit Assessment
BetaThe company will be attending ViVE 2025 Event
Blurb
Dama Health offers insights into unique predispositions, efficacy and side effect profiles.
HQ Location
London (United Kingdom)
Founded
2021
Employees
1 - 10
Total funding raised
$1.00M
Last Funding Event
Undisclosed, $1.00M, June 1, 2023
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of pharmacogenetic technology designed to offer personalized prescribing of hormone therapies in women's health. The company's platform develops software technology and algorithms that match patients to the most personalized hormone therapies, it also conducts academic research on the pharmacogenetics of hormone metabolisms, enabling women and clinicians to have the knowledge to make safe and personalized birth control decisions.